| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/23/1998 | CN1202818A Solubilisation method |
| 12/23/1998 | CN1202370A Method for producing throat smoothing tablet with emblic |
| 12/23/1998 | CN1202358A Medicinal liquid and ointment for curing ache folliculitis and eczema |
| 12/23/1998 | CN1041278C Traditional Chinese medicine capsule for curing premature ejaculation sterility mainly |
| 12/23/1998 | CA2294724A1 Method for producing medicaments containing hmg-coa-reductase inhibitors |
| 12/23/1998 | CA2294519A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | CA2293586A1 A method and an industrial process for determining dose-level characteristics of a multiple unit system |
| 12/23/1998 | CA2291776A1 Aerosol deodorant-antiperspirant product |
| 12/22/1998 | US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
| 12/22/1998 | US5852002 Treatment of conditions and disease |
| 12/22/1998 | US5851992 Treatment of growth hormone deficiency |
| 12/22/1998 | US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor |
| 12/22/1998 | US5851818 Condensed plasmid-liposome complex for transfection |
| 12/22/1998 | US5851670 In vivo-soluble composite particles comprising calcium phosphate |
| 12/22/1998 | US5851579 Aqueous enteric coating compositions |
| 12/22/1998 | US5851555 Controlled release dosage forms containing water soluble drugs |
| 12/22/1998 | US5851553 Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| 12/22/1998 | US5851552 Delivery of controlled-release system(s) |
| 12/22/1998 | US5851551 Sustained-release matrices for dental application |
| 12/22/1998 | US5851550 Pharmaceutical formulations of compacted granulates of β-Lactam antibiotics |
| 12/22/1998 | US5851549 Patch, with system and apparatus for manufacture |
| 12/22/1998 | US5851548 Liposomes containing cationic lipids and vitamin D |
| 12/22/1998 | US5851547 Controlled release drug formulation of open end cylindrical rod form |
| 12/22/1998 | US5851543 Skin care preparation and method |
| 12/22/1998 | US5851539 Fluorocarbon continuous phase water-in-oil emulsions employing silicone surfactants |
| 12/22/1998 | US5851538 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
| 12/22/1998 | US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 12/22/1998 | US5851517 Composition including a dispersion of polymer particles in a non-aqueous medium |
| 12/22/1998 | US5851510 Hepatocyte-selective oil-in-water emulsion |
| 12/22/1998 | US5851454 Spinner head having flow restricting inserts |
| 12/22/1998 | US5851453 Method and apparatus for the formation of particles |
| 12/22/1998 | US5851452 Process for coating droplets or nanometric particles |
| 12/22/1998 | US5851451 Production of microspheres |
| 12/22/1998 | US5851275 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals |
| 12/22/1998 | CA2126699C An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 12/22/1998 | CA2103443C Chewable drug-delivery composition |
| 12/22/1998 | CA2101241C Liposome-encapsulated ciprofloxacin |
| 12/20/1998 | CA2241117A1 Herbal anti-diabetic therapeutic product |
| 12/17/1998 | WO1998056828A1 Method for manufacturing pure guar meal |
| 12/17/1998 | WO1998056431A1 Implant for subcutaneous or intradermal injection |
| 12/17/1998 | WO1998056426A1 Controlled release microencapsulated ngf formulation |
| 12/17/1998 | WO1998056424A1 Biologically active materials |
| 12/17/1998 | WO1998056422A1 Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof |
| 12/17/1998 | WO1998056406A1 Stable insulin formulations |
| 12/17/1998 | WO1998056402A1 Oral formulations for treatment of bacteria-induced diseases of the colon |
| 12/17/1998 | WO1998056398A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| 12/17/1998 | WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein |
| 12/17/1998 | WO1998056370A2 Therapeutic nanospheres |
| 12/17/1998 | WO1998056368A1 Superiority of formulations containing coenzyme q10 in coconut oil |
| 12/17/1998 | WO1998056364A1 IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE |
| 12/17/1998 | WO1998056363A1 Knobby nanospheres |
| 12/17/1998 | WO1998056362A1 Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration |
| 12/17/1998 | WO1998056361A1 Drug targeting system, method of its preparation and its use |
| 12/17/1998 | WO1998056360A2 Film-coated tablet for improved upper gastrointestinal tract safety |
| 12/17/1998 | WO1998056359A2 Compounds which delay the release of active substances |
| 12/17/1998 | WO1998056358A1 Rapamycin formulations for oral administration |
| 12/17/1998 | WO1998056357A1 A controlled release formulation for poorly soluble basic drugs |
| 12/17/1998 | WO1998056356A1 Therapeutically active compositions |
| 12/17/1998 | WO1998056355A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 12/17/1998 | WO1998056354A2 Multiple-unit delayed dosage preparations and method for producing the same |
| 12/17/1998 | WO1998056353A1 Internally supported lipid vesicle systems |
| 12/17/1998 | WO1998056352A1 Novel liposome vectors of active principles |
| 12/17/1998 | WO1998056351A1 Powder compositions of unilamellar liposomes |
| 12/17/1998 | WO1998056350A1 Aerosols |
| 12/17/1998 | WO1998056349A1 Pharmaceutical aerosol composition |
| 12/17/1998 | WO1998056347A1 Release devices |
| 12/17/1998 | WO1998056346A1 Therapeutic or hygienic compositions with controlled and prolonged release of the active principle(s), in particular for ophthalmic use |
| 12/17/1998 | WO1998056334A1 Compositions for delivery of biological agents and methods for the preparation thereof |
| 12/17/1998 | WO1998056325A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
| 12/17/1998 | WO1998056323A1 Device and method for treatment of dysmenorrhea |
| 12/17/1998 | WO1998056259A1 A spinner head having flow restricting inserts |
| 12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 12/17/1998 | WO1998042319A3 Non-aqueous compositions for oral administration |
| 12/17/1998 | WO1998040069A3 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 12/17/1998 | WO1998038983A3 Swallow tablet comprising paracetamol |
| 12/17/1998 | DE19730423C1 Oil-in-water emulsions for cosmetics and pharmaceuticals |
| 12/17/1998 | DE19725911A1 Release retarding composition for production of e.g. tablet |
| 12/17/1998 | DE19725391A1 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren A process for the production of medicaments comprising HMG-CoA reductase inhibitors |
| 12/17/1998 | DE19724605A1 Preparation of hydrophilic, homogeneous, mono:glyceride formulation, |
| 12/17/1998 | CA2303268A1 Therapeutic nanospheres |
| 12/17/1998 | CA2295176A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
| 12/17/1998 | CA2295013A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 12/17/1998 | CA2294334A1 Compositions for delivery of biological agents and methods for the preparation thereof |
| 12/17/1998 | CA2292628A1 Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride |
| 12/17/1998 | CA2291645A1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| 12/17/1998 | CA2291079A1 Method for manufacturing pure guar meal |
| 12/16/1998 | EP0884330A1 Process for producing pure guar seed flour |
| 12/16/1998 | EP0884327A1 Dendritic lysine-based polypeptides for targeted drug delivery |
| 12/16/1998 | EP0884319A2 [1,3]oxazino[3,2-A]indole derivative |
| 12/16/1998 | EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses |
| 12/16/1998 | EP0884053A1 Stable insulin formulations |
| 12/16/1998 | EP0884043A1 Powder-based skin spray |
| 12/16/1998 | EP0884042A1 Medicament and method of treating an organism with medicaments |
| 12/16/1998 | EP0883993A1 Antiviral materials |
| 12/16/1998 | EP0883695A1 Method and composition for hair removal |
| 12/16/1998 | EP0883629A1 Oligopeptides for drug delivery |
| 12/16/1998 | EP0883624A1 Tetraether lipids and liposomes containing said lipids, and use of the same |
| 12/16/1998 | EP0883602A2 Lipids and their use, for example, in liposomes |
| 12/16/1998 | EP0883462A1 Laser drilling process for producing a plurality of holes in chemical dosage forms using acousto-optic deflector |
| 12/16/1998 | EP0883408A1 Ophthalmologically useful composition, products containing the composition and process for disinfecting and/or cleaning contact lenses |